drugset / Trial / NCT00273481

Cosopt Versus Xalacom

NCT00273481

Phase 4 Completed 33 enrolled Pharmaceutical Research Network
RandomizedCrossoverDouble-blindTreatment

Summary

To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.

Timeline

Start
2005-09
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzolamide Small molecule 2 %
Subject Latanoprost Small molecule 0.005 %
Background Timolol Other / unclassified 0.5 %